35 / 67
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 2, March/April 2015
AFRICA
81
USA. Antiretroviral treatment of adult HIV infection: 2008 recom-
mendations of the International AIDS Society-USA.
J Am Med Assoc
2008;
300
(5): 555–570.
77. Paraskevas KI, Hamilton G, Mikhailidis DP. Statins: an essential
component in the management of carotid artery disease.
J Vasc Surg
2007;
46
(2): 373–386.
78. Paraskevas KI, Katsiki N, Tzovaras AA, Koupidis SA, Mikhailidis DP.
Peripheral arterial disease and HIV-positive patients.
Angiology
2011;
62
(1): 7–9.
79. Triant VA, Grinspoon SK. Immune dysregulation and vascular risk in
HIV-infected patients: implications for clinical care.
J Infect Dis 2011
;
203
(4): 439–441.
80. Gilliam BL, Riedel DG, Redfield RR. Clinical use of CCR5 inhibitors
in HIV and beyond.
J Transl Med
2010;
9
(Suppl): S9–S14.
81. Qaqa AY, DeBari VA, Isbitan A,
et al
. The role of post-exercise meas-
urements in the diagnosis of peripheral arterial disease in HIV-infected
patients.
Angiology
2011;
62
(1): 10–14.